Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 54INDUSTRY 24NIH 8NETWORK 2OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 13Neoplasms 11Breast Neoplasms 11Carcinoma, Hepatocellular 10Prostatic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Stomach Neoplasms 5Lung Neoplasms 5Anastomotic Leak 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Lymphoma, Follicular 4Stomatitis 3Pancreatic Neoplasms 3Multiple Myeloma 3HIV Infections 3Disease 3Depression 3Vulvar Neoplasms 2Surgical Wound Infection 2Sleep Initiation and Maintenance Disorders 2Skin Neoplasms 2Sarcoma 2Postoperative Complications 2Peritoneal Neoplasms 2Neuroendocrine Tumors 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Motor Activity 2

Interventions

Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Kidney Neoplasms × 90 days × Clear all
NCT07485114 2026-03-20

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Tel-Aviv Sourasky Medical Center

Recruiting
300 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡